Member Info for highlandmatt

Do you really want your CEO stating that the bank thinks the balance sheet is weak, or that you've been told to place in advance? Helium One was a lesson in what happens then.

400m shares in issue, so £200m is 50p... still not a lot for a biotech with global application.

Preferable to us, but we have a commitment to the bank. Unless that can be renegotiated.

I hasten to add, core holding always retained. A barnstorming RNS could land any time.

I'm certainly making consistent money buying around 1.5p and selling above 2p. Small amounts, but keeps the portfolio ticking.

Portillion was never putting up £10m themselves. They are a broker.

NEDs also bought a year ago. Look at the Directors Deals. They got lucky?

GGG - you can find PB's email on the back of the corporate presentations. However, it might be worth not distracting the BoD at this time, we want 100% focus on resolving the issue. Also, you might want to consider the implications of stating that the company/ CEO has lied - it might be considered libelous.

Canada showing buys at 13p equivalent?

Higher risk, higher rewards.

So, what do we know? CB has been acquired with RBL of $30m, but it appears the bank required TXP to raise $18m by 31 Dec 2025. Oak contracted for £15m with £10m to be provided by Portillion Capital. Unfortunately, Portillion have not come up with the readies. The SP has tanked accordingly. Legal and regulatory avenues to enforce the contract are being explored. In the meantime, we understand CB is running well and Cas 5 logging is commencing. So operationally production continues, revenues are received. TXP has time to sort the mess out. Once resolved, SP should return to 20p plus.

The RNS in Canada says something slightly different.

If anything, it is the other way around. The loan for the acquisition was contingent on the placing.

Revenue about $20m a quarter now with CB. Debt repayments about $3.5m. Will be fine.

Two producing gas facilities, plus oil production. Another well to come on soon? Topped up.

Stating sand thickness is not sharing well logs.

I remember Ross complaining about the raise that funded Cas1.

CB benefits are already here. Low decline production at good sales prices. That cashflow, along with Cas cashflow, underpins the company.

As the purchase price is in dollars, it requires fewer shares to satisfy, so less dilution.

Yes, and Touchstone my only oil producer which isn't!